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One of the striking characteristics of cancer cells is their phenotypic diversity and ability to switch phenotypes in
response to environmental fluctuations. Such phenotypic changes (e.g. from drug-sensitive to drug-resistant), which
are critical for survival and proliferation, are widely believed to arise due to mutations in the cancer cell’s genome.
However, there is growing concern that such a deterministic view is not entirely consistent with multiple lines of
evidence which indicate that cancer can arise in the absence of mutations and can even be reversed to normalcy
despite the mutations. In this Commentary, we wish to present an alternate view that highlights how stochasticity
in protein interaction networks (PINs) may play a key role in cancer initiation and progression. We highlight the
potential role of intrinsically disordered proteins (IDPs) and submit that targeting IDPs can lead to new insights and
treatment protocols for cancer.In light of the incessant deluge of data that often show
meager correlations to cancer cause, diagnosis or prog-
nosis, one wonders whether cancer is indeed a genetic
disease and whether all cancers arise as a result of
changes in the cancer cell’s genome as is commonly be-
lieved [1,2]. Such a view implying that cancer is deter-
ministic, perhaps raises more difficulties rather than
provide a clearer understanding of the disease [3,4]. In
the following, we focus on a single example which is il-
lustrative of the kind of difficulties we are dealing with.
Conventional wisdom suggests that cancer cells con-
tain so many mutations that their reversal to normalcy is
unlikely. This belief has led to the development of treat-
ments aimed at killing cancer cells – an ambitious aim
that has been difficult, if not impossible, to achieve for
most cancers. However, in 2004, a landmark paper by
Felsher and coworkers [5] startled the cancer world by
demonstrating that indeed, rogue tumor cells can be re-
formed. By conditionally turning on the oncogene c-Myc
in mice hepatocytes with the Tet system, the authors in-
duced hepatocellular carcinoma in these transgenic ani-
mals. They then turned off Myc expression in these
animals and surprisingly observed that Myc inactivation
resulted en masse in tumour cells differentiating into* Correspondence: pkulkar4@jhmi.edu
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reproduction in any medium, provided the orhepatocytes and biliary cells forming bile duct structures.
This was accompanied by a rapid loss of expression of
the tumour marker α-fetoprotein and increase in expres-
sion of liver cell markers such as cytokeratin 8 and
carcinoembryonic antigen demonstrating how oncogene
inactivation may reverse tumorigenesis in the most clin-
ically difficult cancers. In other words, the cancerous he-
patocytes had turned normal albeit, dormant. However,
turning Myc on again resulted in the dormant cells
redeveloping cancer. Remarkably, the authors confirmed
that the genomic alterations that had occurred in the
cancer cells overproducing Myc remained unchanged
when the Myc-expressing cells cycled between the can-
cerous and ‘normal’ states!
As tantalizing as these observations were, they natur-
ally lead to the question: how does the cancer cell turn
‘normal’ if mutations were driving tumorigenesis? In
light of these, and numerous other similar observations
[6-9] over the last 50 years, several groups have won-
dered whether genetic alterations are merely a result of
cancer rather than the cause. In this brief Commentary,
we would like to present an alternate view, emphasizing
a stochastic rather than deterministic underpinning.
It is now widely accepted that stochasticity or noise in
gene expression can give rise to phenotypic variations
among clonal cells in homogeneous environments
[10,11]. Thus, in response to the same stimulus, two
genetically identical cells can display very different pheno-
types, and it has been argued that this inherent stochasticity
can serve as a key driving force for tumorigenesis [12].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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evidence indicates that the information transduced in cellu-
lar signaling pathways is also significantly affected by noise
[13]. It has been proposed that, noise in these pathways
may be generated by the interconnected and promiscuous
nature of protein interactions that are necessary to trans-
duce signals [13]. However, how this noise arises and what
consequences it has on cell fate is poorly understood.
A potential clue [14] can be obtained from a remark-
able study by Vavouri et al. [15] that demonstrated a
strong correlation between the overexpression of intrin-
sically disordered proteins (IDPs) and altered physio-
logical states in model organisms. IDPs are proteins that
lack a rigid 3D structure at least in vitro [16]. However,
a remarkable feature of most IDPs is their ability to
undergo disorder-to-order transitions upon binding to
their biological target (coupled folding and binding) [17].
Structural flexibility and plasticity are believed to repre-
sent a major functional advantage for the IDPs enabling
them to interact with a broad range of binding partners
[18]. Therefore, it was postulated that IDPs are prone
to initiate promiscuous molecular interactions when
overexpressed resulting in altered physiological states
[15,19]. Consistent with this argument, several onco-
genes [20], and other cancer-associated genes [21]
that are overexpressed in cancer, encode IDPs. This
idea that IDP-initiated promiscuity can result in
pathological effects in the absence of any genetic al-
terations may also help explain the remarkable resultsFigure 1 Schematic representation of phenotypic switching driven by
normal cell that is characterized by a specific configuration of its protein in
certain intrinsically disordered proteins (IDPs) go up and promote promiscu
rewired PIN remain within the threshold characteristic of phenotype A, this
network topology. However, if the search unmasks latent PIN configuration
represented by phenotype B. Each cell has the same probability of switchin
(vertical line) the majority of cells in the population will be in phenotype Bof Shachaf et al. [5] that focus on Myc which is an
IDP [20].
We hypothesized [14] that noise in protein interaction
networks (PINs) contributed by the conformational dy-
namics of IDPs may play a critical role in phenotypic
switching. More specifically, we posited that this con-
formational noise due to the stochastic interactions initi-
ated by the IDPs in response to a specific input, allow
the system to sample through the network interaction
space and drive transitions that generate phenotypic het-
erogeneity. Thus, IDPs can rewire PINs and, by explor-
ing the network interaction space, activate previously
masked options potentially resulting in a transition from
one state (phenotype) to another.
In this stochastic model, each cell has equal probability
to undergo a specific phenotypic transition in response
to the given input. Indeed, such stochasticity in pheno-
typic switching is also thought to underlie cellular differ-
entiation [22], generation of induced pluripotent stem
cells (iPS cells) [23] and emergence of cancer stem
cells from non-stem cancer cells [24]. Implicit in our
model, the PIN configuration contains information
that specifies the cell’s phenotype. Furthermore, as
depicted in Figure 1, we posit that the network is flex-
ible in responding to physiological changes but robust
in response to adverse perturbations. However, as the
perturbation increases, there is an increasing likeli-
hood that the PIN rewires itself by unmasking latent
network connections and causes the cell to transitionnoise in protein interaction networks. Phenotype A represents a
teraction network (PIN). When subjected to perturbations, the levels of
ous interactions to rewire the PIN. If the new configurations of the
phenotype is retained notwithstanding minor fluctuations in the
s that cross the threshold, the cell transitions to a cancer cell
g to phenotype B, and once the perturbation exceeds a threshold
.
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normal (non-dividing) to a malignant (proliferation)
phenotype when Myc is overexpressed (Figure 1). But
it is important to note that, depending on the network
topology, lowering the perturbation (e.g. turning off
Myc expression) can result in the PIN again rewiring
itself to the normal (default) network configuration,
thereby reversing the phenotypic switch (malignant to
normal). Interestingly, a similar situation is encountered
in stem cells where sustained Myc expression is critical to
maintain the pluripotent state; downregulating Myc
promotes differentiation of these cells [25]. Conversely,
overexpression of Myc in dormant cells kicks them
into a proliferative mode.
But how might information residing in PINs be
transmitted so that it can be stably inherited? It is now
widely accepted that information that is transmitted
transgenerationally can be encoded epigenetically. Inter-
estingly, several proteins that are involved in epigenetically
sculpting the chromatin are IDPs suggesting that rewiring
of protein networks could result in heritable epigenetic
changes [14 and cfs therein]. Thus we conjectured [14]
that, working together, these changes in the PIN instituted
by the IDPs could account for stochastic phenotypic
switching.
Cancer cells, like all other living (cells, organisms, and
ecosystems) and many non-living systems in the uni-
verse (stars and galaxies), are self-organizing systems
that exhibit nonlinear dynamics. However cancer cells,
unlike their normal counterparts, exhibit traits typically
associated with primitive, single-celled organisms such
as bacteria that have an amazing adaptive tenacity
[26,27]. As a result, it has been difficult to treat cancer.
Thus, several groups [28], in particular, Huang and co-
workers who have advanced the cancer attractor concept
[4,29,30], have argued that there needs to be a paradigm
shift from the prevailing view of cancer that is strongly
influenced by fundamentally deterministic approaches.
By applying the tools of nonlinear dynamics, network
theory and stochastic modeling in combination with ex-
periments to characterize cancer protein network con-
nectivity and functionality we need to decipher how
cancer cells self-organize to generate phenotypic hetero-
geneity by different mechanisms. This knowledge can
potentially lead to a more fundamental understanding of
cancer and to the development of more effective thera-
peutics. Perhaps, similar ideas may have already been
deployed by Nature. For example, a recent study
concerning certain plant pathogens found that they se-
lectively deploy independently evolved virulence proteins
that interact with a limited set of highly connected cellu-
lar hubs in order to take control of host cells [31]. The
latter should serve as an inspiration, not just as a para-
digm, to go after IDPs especially, those that areaberrantly expressed only in cancer cells such as the
Cancer/Testis Antigens. Are we tilting at windmills
instead?
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